Associations between self-reported PrEP use and short and long-term pharmacologic metrics of PrEP adherence among Kenyan women
BACKGROUND: Biomarkers provide reliable information on oral PrEP pill-taking. It remains unclear whether self-reported PrEP adherence has value when used in combination with pharmacologic measures. We examined associations between self-reported and biomarker-based PrEP adherence metrics to improve identification of those with low adherence in resource-constrained settings. METHODS: HIV-uninfected women using oral tenofovir (TFV)-based PrEP were enrolled (N=100) in the Point-of-Care Urine Monitoring for Adherence trial in Kenya from 2021-2022. Participants were randomized 1:1 to standard-of-care or urine-based-point-of-care assay-informed drug-level feedback. Adherence was measured at enrollment and quarterly through 12 months via urine, hair and self-report. A positive urine assay (TFV≥1500 ng/mL) indicated short-term adherence. TFV hair concentration≥0.023 ng/mg indicated long-term adherence (4-times-weekly dosing). Self-reported adherence was calculated as the mean score (range=0-100) on a 2-item scale. Generalized estimating equations estimated longitudinal associations between self-reported adherence and biomarkers. Receiver-operating-characteristic curves assessed self-report as a predictor of biomarker metrics. RESULTS: At enrollment, 68.7% had a positive urine assay, 83.7% had detectable hair TFV, and median self-reported adherence was 100 (IQR=90-100). At Month 12, participants with higher adherence scores were more likely to have hair TFV concentrations≥0.023 ng/mg (aRR=1.44; 95% CI=1.20-1.72; p-value<0.001) and positive urine results (aRR=1.56; CI=1.43-1.69; p-value=<0.001). Areas-under-the-curve for self-report as a predictor of hair levels were 0.64 in a model with self-report and 0.74 in a model with both self-report and urine testing. CONCLUSIONS: Associations between self-reported and biomarker-verified PrEP adherence demonstrated accurate reporting. Incorporating biomarkers in studies may result in improved adherence and/or improved accuracy of self-report.
Authors
- Charlene Biwott
- Jennifer Velloza (ORCID: https://orcid.org/0000-0001-7242-7415)
- Matthew A. Spinelli (ORCID: https://orcid.org/0000-0001-6368-8664)
- Gakuo Maina
- David V. Glidden (ORCID: https://orcid.org/0000-0001-5888-1419)
- Hideaki Okochi (ORCID: https://orcid.org/0000-0002-8519-7409)
- Catherine Kiptinness (ORCID: https://orcid.org/0000-0002-2647-0196)
- Deepalika Chakravarty
- Aliza Adler
- Nelly Mugo
- Monica Gandhi
- Purba Chatterjee
- Kenneth Ngure
Institutions
- University of California, San Francisco (US)
- University of Washington (US)
- Jomo Kenyatta University of Agriculture and Technology (KE)
- Kenya Medical Research Institute (KE)
- Partners for Health and Development in Africa (KE)
- University of San Francisco (US)
Publication Details
- Journal
- JAIDS Journal of Acquired Immune Deficiency Syndromes
- Published
- 2026-09-04
- DOI
- https://doi.org/10.1097/qai.0000000000003967
- Primary Topic
- HIV/AIDS Research and Interventions
- Type
- article
- Field-Weighted Citation Impact
- 0.00